Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Bicycle Therapeutics Plc ADR (NASDAQ: BCYC) closed at $7.40 down -18.32% from its previous closing price of $9.06. In other words, the price has decreased by -$18.32 from its previous closing price. On the day, 0.58 million shares were traded.
Ratios:
For a deeper understanding of Bicycle Therapeutics Plc ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.86 and its Current Ratio is at 14.86. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on November 08, 2024, initiated with a Equal-Weight rating and assigned the stock a target price of $25.
On September 06, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $35.
B. Riley Securities Downgraded its Buy to Neutral on August 07, 2024, whereas the target price for the stock was revised from $33 to $28.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 02 ’25 when Young Alethia sold 215 shares for $8.02 per share. The transaction valued at 1,724 led to the insider holds 45,390 shares of the business.
Skynner Michael sold 1,038 shares of BCYC for $7,764 on Apr 03 ’25. The CHIEF TECHNOLOGY OFFICER now owns 121,870 shares after completing the transaction at $7.48 per share. On Apr 02 ’25, another insider, Skynner Michael, who serves as the CHIEF TECHNOLOGY OFFICER of the company, sold 814 shares for $8.02 each. As a result, the insider received 6,528 and left with 122,908 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 19.88 while its Price-to-Book (P/B) ratio in mrq is 0.69.
Stock Price History:
Over the past 52 weeks, BCYC has reached a high of $28.67, while it has fallen to a 52-week low of $6.10. The 50-Day Moving Average of the stock is -16.34%, while the 200-Day Moving Average is calculated to be -57.37%.
Shares Statistics:
A total of 69.20M shares are outstanding, with a floating share count of 61.43M. Insiders hold about 11.24% of the company’s shares, while institutions hold 54.10% stake in the company.
